CUA guideline on adult overactive bladder.
作者信息
Corcos Jacques, Przydacz Mikolaj, Campeau Lysanne, Gray Gary, Hickling Duane, Honeine Christiane, Radomski Sidney B, Stothers Lynn, Wagg Adrian, Lond Frcp
机构信息
Department of Urology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Northern Alberta Urology Centre, Edmonton, AB, Canada.
出版信息
Can Urol Assoc J. 2017 May;11(5):E142-E173. doi: 10.5489/cuaj.4586. Epub 2017 May 9.
Abstract
摘要
相似文献
1
CUA guideline on adult overactive bladder.
Can Urol Assoc J. 2017 May;11(5):E142-E173. doi: 10.5489/cuaj.4586. Epub 2017 May 9.
2
Appendix: Executive summary of CUA guideline on adult overactive bladder.
Can Urol Assoc J. 2017 May;11(5):E248-E249. doi: 10.5489/cuaj.4694. Epub 2017 May 9.
3
2023 UPDATE - Canadian Urological Association guideline: Management of cystic renal lesions Prior to original publication (March 2017), this guideline underwent review by the CUA Guidelines Committee, CUA members at large, and the CUA Executive Board. The 2023 updates were app roved by the CUA Guidelines Committee and CUA Executive Board.
Can Urol Assoc J. 2023 Jun;17(6):162-174. doi: 10.5489/cuaj.8389.
4
European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence.
Eur Urol. 2022 Jul;82(1):49-59. doi: 10.1016/j.eururo.2022.01.045. Epub 2022 Feb 23.
5
Nocturia Quality-of-Life questionnaire is a useful tool to predict nocturia and a risk of falling in Japanese outpatients: a cross-sectional survey.
Int J Urol. 2014 Mar;21(3):289-93. doi: 10.1111/iju.12242. Epub 2013 Aug 29.
6
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019.
J Urol. 2019 Sep;202(3):558-563. doi: 10.1097/JU.0000000000000309. Epub 2019 Aug 8.
7
Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE).
Bladder Cancer. 2016 Jan 7;2(1):27-36. doi: 10.3233/BLC-150034.
8
The Overactive Bladder and the AUA Guidelines: A Proposed Clinical Pathway for Evaluation and Effective Management in a Contemporary Urology Practice.
Urol Pract. 2016 Sep;3(5):399-405. doi: 10.1016/j.urpr.2016.01.004. Epub 2016 Jul 1.
9
The patient perspective on overactive bladder: a mixed-methods needs assessment.
BMC Fam Pract. 2014 May 14;15:96. doi: 10.1186/1471-2296-15-96.
10
Treatments for overactive bladder: focus on pharmacotherapy.
J Obstet Gynaecol Can. 2012 Nov;34(11):1092-1101. doi: 10.1016/S1701-2163(16)35440-8.
引用本文的文献
1
Overactive bladder drugs and the risk of dementia.
BMJ Med. 2025 Apr 15;4(1):e001520. doi: 10.1136/bmjmed-2025-001520. eCollection 2025.
2
Comparative efficacy and adverse effects of β3-agonists and antimuscarinics in overactive bladder: a network and component network meta-analysis.
Eur J Clin Pharmacol. 2025 Jun 7. doi: 10.1007/s00228-025-03855-1.
3
Women suffering from overactive bladder syndrome exhibit a higher urethral viral abundance compared to healthy controls: a pilot study.
Sci Rep. 2025 Jun 3;15(1):19484. doi: 10.1038/s41598-025-98780-9.
4
Association between triglyceride glucose-waist height ratio index and overactive bladder: based on NHANES 2005-2018.
Front Endocrinol (Lausanne). 2025 Apr 15;16:1541218. doi: 10.3389/fendo.2025.1541218. eCollection 2025.
5
Efficacy and safety of Solifenacin combined with Mirabegron in treating overactive bladder in female patients following bladder instillation for bladder cancer.
Am J Transl Res. 2025 Feb 15;17(2):1144-1152. doi: 10.62347/BXQN5596. eCollection 2025.
6
Lidocaine solution vs. lidocaine gel instillation for pain management during intravesical botulinum injections.
Can Urol Assoc J. 2025 Jun;19(6):189-192. doi: 10.5489/cuaj.9011.
7
Efficacy and safety of sacral nerve root magnetic stimulation combined with solifenacin in female patients with overactive bladder.
Am J Transl Res. 2025 Jan 15;17(1):685-692. doi: 10.62347/EHTT9544. eCollection 2025.
8
Efficacy and safety of pelvic floor magnetic stimulation combined with mirabegron in female patients with refractory overactive bladder: a prospective study.
Front Neurosci. 2024 Apr 10;18:1373375. doi: 10.3389/fnins.2024.1373375. eCollection 2024.
9
2024 Canadian Urological Association guideline: Female stress urinary incontinence.
Can Urol Assoc J. 2024 Apr;18(4):83-102. doi: 10.5489/cuaj.8751.
10
Radiofrequency as the New Opportunity in Treating Overactive Bladder and Urge Urinary Incontinence-A Single-Arm Pilot Study.
Medicina (Kaunas). 2024 Jan 24;60(2):197. doi: 10.3390/medicina60020197.
本文引用的文献
1
Treatment compliance of working persons to high-dose antimuscarinic therapies: a randomized trial.
Ther Adv Urol. 2016 Aug;8(4):239-248. doi: 10.1177/1756287216652030. Epub 2016 Jun 3.
2
Evaluating Outcomes in Patients with Overactive Bladder within an Integrated Healthcare Delivery System Using a Treatment Patterns Analyzer.
Am Health Drug Benefits. 2016 Sep;9(6):343-353.
3
Critical evaluation of the overactive bladder and urgency urinary incontinence association with obstructive sleep apnea syndrome in a relatively young adult male population.
Neurourol Urodyn. 2017 Sep;36(7):1804-1808. doi: 10.1002/nau.23184. Epub 2016 Dec 6.
4
Long-term Persistence with Mirabegron versus Solifenacin in Women with Overactive Bladder: Prospective, Randomized Trial.
Low Urin Tract Symptoms. 2018 May;10(2):148-152. doi: 10.1111/luts.12151. Epub 2016 Dec 2.
5
Is Preoperative Assessment and Treatment of Asymptomatic Bacteriuria Necessary for Reducing the Risk of Postoperative Symptomatic Urinary Tract Infections After Urologic Surgical Procedures?
Urology. 2017 Jan;99:100-105. doi: 10.1016/j.urology.2016.10.016. Epub 2016 Oct 20.
6
Social Media in Urology: opportunities, applications, appropriate use and new horizons.
Cent European J Urol. 2016;69(3):293-298. doi: 10.5173/ceju.2016.848. Epub 2016 Sep 16.
7
The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population.
BMC Urol. 2016 Oct 6;16(1):60. doi: 10.1186/s12894-016-0179-x.
8
OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.
JAMA. 2016 Oct 4;316(13):1366-1374. doi: 10.1001/jama.2016.14617.
9
Evaluation and management of overactive bladder: strategies for optimizing care.
Res Rep Urol. 2016 Jul 27;8:113-22. doi: 10.2147/RRU.S93636. eCollection 2016.
10
Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY).
World J Urol. 2017 May;35(5):827-838. doi: 10.1007/s00345-016-1908-1. Epub 2016 Aug 11.
Zotero 插件